Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;34(6):e23225.
doi: 10.1002/jcla.23225. Epub 2020 Feb 11.

Diagnostic performance of reticulocyte hemoglobin equivalent in assessing the iron status

Pawadee Chinudomwong  1 , Aleeyas Binyasing  1 , Rangsiri Trongsakul  1 , Karan Paisooksantivatana  1
Affiliations

Diagnostic performance of reticulocyte hemoglobin equivalent in assessing the iron status

Pawadee Chinudomwong et al. J Clin Lab Anal. 2020 Jun.

Abstract

Background: Measurement of reticulocyte hemoglobin equivalent (RET-He) is rapid, convenient, and cost-effective. Yet, researches on its performance in diagnosing iron deficiency with concurrent inflammation are limited. Hence, this study investigated RET-He value in various states, including inflammation, and evaluated its diagnostic performance in iron status assessment.

Methods: Retrospectively, 953 clinical data and laboratory results-complete blood count, reticulocyte count, RET-He, and serum ferritin-were reviewed. Patients on iron therapy were excluded. Iron status was defined by serum ferritin as the reference method. RET-He among populations was investigated. Its diagnostic performance and optimal cutoff were determined by ROC analysis.

Results: Three population groups were classified: healthy control, iron deficiency anemia (IDA), and non-ID anemia. Significantly, RET-He value in IDA was lower than that of healthy control, anemia of inflammation, and chronic kidney disease (P < .0001). Low RET-He was also observed in IDA with concomitant inflammation despite normal-to-high serum ferritin levels. No significant difference was observed between RET-He values in pure IDA and thalassemia (P = .57). ROC curve analysis revealed AUC of 0.876 (P < .0001) at cutoff 30 pg, by which IDA was discriminated with 74.2% sensitivity and 97.4% specificity. Applying cutoff ≤30 pg, IDA can be diagnosed with 96% sensitivity, 97.4% specificity, 80% PPV, and 99.6% NPV. Hence, RET-He >30 pg signifies a non-IDA state.

Conclusion: In addition to convenience and cost-effectiveness, RET-He cutoff >30 pg can be potentially used to exclude IDA due to its excellent diagnostic sensitivity and specificity.

Keywords: diagnostic performance; exclusion; inflammation; iron deficiency anemia; reticulocyte hemoglobin equivalent (RET-He).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study populations. Diagnostic criteria for each population group: (1) Healthy control: absence of clinical symptom, Hb ≥ 120 g/L (W) or ≥ 130 g/L (M), MCV 80‐100 fL, MCH 27‐31 pg, WBC count 4.0‐10.0 x 109/L, platelet count 150‐450 x 109/L, and serum ferritin 33.71‐674.16 pmol/L; (2) IDA: Hb < 120 g/L (W) or < 130 g/L (M), MCV < 80 fL, MCH < 27 pg, Reticulocyte Production Index (RPI) <2, and serum ferritin < 33.71 pmol/L or ferritin ≥ 33.71 pmol/L with clinical diagnosis of IDA; (3) IDA‐inf: Hb < 120 g/L (W) or < 130 g/L (M), MCV < 80 fL, MCH < 27 pg, and serum ferritin ≥ 33.71 pmol/L in presence of inflammation; (4) Anemia of inflammation: Hb < 120 g/L (W) or < 130 g/L (M), MCV 80‐100 fL, MCH 27‐31 pg, and serum ferritin ≥ 33.71 pmol/L with associated inflammatory conditions; (5) Anemia of chronic renal insufficiency: Hb < 120 g/L (W) or < 130 g/L (M), MCV 80‐100 fL, MCH 27‐31 pg, and serum ferritin ≥ 33.71 pmol/L in patients diagnosed of CKD; (6) Thalassemia: Hb < 120 g/L (W) or < 130 g/L (M), MCV < 80 fL, MCH <27 pg, and Hb typing and/or DNA analysis results demonstrating alpha and/or beta thalassemia
Figure 2
Figure 2
RET‐He values among the population groups. Box‐and‐Whisker plot illustrates RET‐He values among six population groups in this study. Comparison of values between groups is performed by the Kruskal‐Wallis test (P < .05)
Figure 3
Figure 3
Optimal RET‐He cutoff. RET‐He cutoff value in distinguishing IDA is optimally determined by ROC analysis. Cutoff ≤30 pg demonstrates AUC of 0.876 (74.2% sensitivity, 97.4% specificity; P < .001)
Figure 4
Figure 4
Proposed diagnostic algorithm. Evaluation of RET‐He is incorporated into the proposed diagnostic algorithm. At RET‐He cutoff >30 pg, IDA is excluded. As IDA can co‐exist with non‐ID conditions, ferritin still plays a role in the confirmation of such condition
See this image and copyright information in PMC

References

    1. Ennis KM, Dahl LV, Rao RB, Georgieff MK. Reticulocyte hemoglobin content as an early predictive biomarker of brain iron deficiency. Pediatr Res. 2018;84(5):765‐769. - PMC - PubMed
    1. Speeckaert MM, Speeckaert R, Delanghe JR. Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci. 2010;47(5–6):213‐228. - PubMed
    1. Food and Agriculture Organization of the United Nations, World Health Organization . Chapter 13. Iron [Internet]. Rome: food and agriculture organization. 2001:195‐221 [cited 2017 Nov 11]. Available from: http://www.fao.org/3/a-y2809e.pdf
    1. Peerschke EIB, Pessin MS, Maslak P. Using the hemoglobin content of reticulocytes (RET‐He) to evaluate anemia in patients with cancer. Am J Clin Pathol. 2014;142(4):506‐512. - PMC - PubMed
    1. Ganz T. Iron deficiency and overload In: Kaushansky K, Prchal JT, Press OW, Lichtman MA, Levi M, Burns LJ, Caligiuri MA, eds. Williams Hematology (9th edn). New York, NY: McGraw‐Hill Education; 2016:627‐637.